Literature DB >> 32759259

SARS CoV-2 infection among patients using immunomodulatory therapies.

Kevin L Winthrop1,2, Amanda E Brunton3, Susan Beekmann4, Philip Polgreen4, John Baddley5, Kenneth G Saag6, Cassandra Calabrese7, Leonard Calabrese7, Philip C Robinson8, Zachary S Wallace9, Jeffrey R Curtis6.   

Abstract

Entities:  

Keywords:  arthritis; autoimmune diseases; biological therapy; rheumatoid

Mesh：

Substances：

Year:  2020        PMID： 32759259     DOI： 10.1136/annrheumdis-2020-218580

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Corticosteroid injections during the COVID-19 pandemic: experience from a UK centre.

Authors:  David McKean; Siok Li Chung; Rory Fairhead; Oliver Bannister; Malgorzata Magliano; Joseph Papanikitas; Nick Wong; Richard Hughes
Journal:  Bone Jt Open       Date:  2020-09-28

2.  Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy.

Authors:  Özlem Pehlivan; Tutku Aydin
Journal:  Ann Saudi Med       Date:  2022-06-02       Impact factor: 1.707

3.  Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database.

Authors:  Yuwei Sun; D Claire Miller; Idara Akpandak; Evan M Chen; Benjamin F Arnold; Nisha R Acharya
Journal:  Ophthalmology       Date:  2022-05-17       Impact factor: 14.277

Review 4.  The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19.

Authors:  Philip C Robinson; David F L Liew; Jean W Liew; Claudia Monaco; Duncan Richards; Senthuran Shivakumar; Helen L Tanner; Marc Feldmann
Journal:  Med (N Y)       Date:  2020-12-03

5.  The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?

Authors:  N Winchester; C Calabrese; L H Calabrese
Journal:  Pathog Immun       Date:  2021-03-08

6.  Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network.

Authors:  Rahul Raiker; Haig Pakhchanian; Chengappa Kavadichanda; Latika Gupta; Sinan Kardeş; Sakir Ahmed
Journal:  Clin Rheumatol       Date:  2021-11-27       Impact factor: 3.650

7.  Sarcoidosis following SARS-CoV-2 infection: Cause or consequence?

Authors:  Esther Palones; Virginia Pajares; Laura López; Diego Castillo; Alfons Torrego
Journal:  Respirol Case Rep       Date:  2022-04-27

Review 8.  COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.

Authors:  Jason D Goldman; Philip C Robinson; Thomas S Uldrick; Per Ljungman
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.